The rising interest in GLP-1 agonists for metabolic conditions has led to a discussion about delivery routes : skin-applied devices versus pills . Usually , GLP-1 therapies were only available in tablet form, but the introduction of transdermal delivery provides a new way. Transdermal systems might be advantageous for individuals with difficulty… Read More